Clinical Trials Browser

Interventional × Gliosarcoma × Cytoreduction Surgical Procedures × Clear all

NCT01257594 2023-05-25

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma